Feb 19, 2023
Harold Punnett DMD, co-founder, NervGen Pharma Corp describes the origins of the business as ‘a story of tragedy, a hope and a dream, and one for which the end is yet to be written’ in Jan Cavelle’s new book: Start for Success: The Entrepreneur’s Guide to Start-Ups is available at Amazon.com in Canada, the United States, United Kingdom and Australia.
New book by Jan Cavelle includes feature interview with NervGen co-founder, Dr. Harold Punnett
NervGen Pharma Corp (“NervGen”) (TSXV: NGEN) (OTCQB: NGENF), is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic disorders. NervGen’s lead candidate, NVG-291, is a first- and potential best-in-class candidate being evaluated in the Phase 1b/2a CONNECT SCI Study in individuals living with spinal cord injury.
Contact
112-970 Burrard Street
Unit 1290
Vancouver, BC V6Z 2R4
Phone: (778) 731-1711
Email: [email protected]